APA (7th ed.) Citation

A, K., R, M., OA, S., E, R., XM, W., A, U., . . . JJ, A. (2025). LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer. Neoplasia (New York, N.Y.), 63, 101151. https://doi.org/10.1016/j.neo.2025.101151

Chicago Style (17th ed.) Citation

A, Kumaraswamy, et al. "LSD1+8a Is an RNA Biomarker of Neuroendocrine Prostate Cancer." Neoplasia (New York, N.Y.) 63 (2025): 101151. https://doi.org/10.1016/j.neo.2025.101151.

MLA (9th ed.) Citation

A, Kumaraswamy, et al. "LSD1+8a Is an RNA Biomarker of Neuroendocrine Prostate Cancer." Neoplasia (New York, N.Y.), vol. 63, 2025, p. 101151, https://doi.org/10.1016/j.neo.2025.101151.